Sophie V. Vandebroek - 05 Mar 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Issuer symbol
IDXX
Transactions as of
05 Mar 2024
Transactions value $
-$445,338
Form type
4
Filing time
07 Mar 2024, 17:00:23 UTC
Previous filing
16 Feb 2024
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $345K +1.4K +115.46% $245.79 2.62K 05 Mar 2024 Direct
transaction IDXX Common Stock Sale -$790K -1.4K -53.59% $562.98 1.22K 05 Mar 2024 Direct F1
holding IDXX Common Stock 8.17K 05 Mar 2024 By Sophie V. Vandebroek Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -1.4K -100% 0 05 Mar 2024 Common Stock 1.4K $245.79 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $562.9801 to a high of $563.2160 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 6, 2020.
F3 Not applicable.